Silexion Therapeutics Corp (SLXN) concluded trading on Wednesday at a closing price of $0.92, with 5.39 million shares of worth about $4.96 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -51.85% during that period and on May 21, 2025 the price saw a gain of about 1.82%. Currently the company’s common shares owned by public are about 8.69M shares, out of which, 7.91M shares are available for trading.
Stock saw a price change of -4.14% in past 5 days and over the past one month there was a price change of 30.97%. Year-to-date (YTD), SLXN shares are showing a performance of -54.19% which decreased to -99.06% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.57 but also hit the highest price of $122.02 during that period. The average intraday trading volume for Silexion Therapeutics Corp shares is 4.52 million. The stock is currently trading -4.01% below its 20-day simple moving average (SMA20), while that difference is down -6.81% for SMA50 and it goes to -88.02% lower than SMA200.
Silexion Therapeutics Corp (NASDAQ: SLXN) currently have 8.69M outstanding shares and institutions hold larger chunk of about 10.41% of that.
The stock has a current market capitalization of $8.00M and its 3Y-monthly beta is at 0.06. It has posted earnings per share of -$19.77 in the same period. It has Quick Ratio of 3.22 while making debt-to-equity ratio of 1.34. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SLXN, volatility over the week remained 8.49% while standing at 11.23% over the month.
Stock’s fiscal year EPS is expected to rise by 96.51% while it is estimated to decrease by -17.39% in next year. EPS is likely to grow at an annualized rate of 63.05% for next 5-years, compared to annual growth of -286.10% made by the stock over the past 5-years.
